Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving the Stratification of Patients With Intermediate-risk Prostate Cancer.
Stolzenbach LF, Nocera L, Collà-Ruvolo C, Tian Z, Knipper S, Maurer T, Tilki D, Graefen M, Karakiewicz PI. Stolzenbach LF, et al. Among authors: maurer t. Clin Genitourin Cancer. 2021 Apr;19(2):e120-e128. doi: 10.1016/j.clgc.2020.11.003. Epub 2020 Nov 10. Clin Genitourin Cancer. 2021. PMID: 33358891 Clinical Trial.
Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R. Heck MM, et al. Among authors: maurer t. Clin Cancer Res. 2018 May 15;24(10):2342-2349. doi: 10.1158/1078-0432.CCR-17-3771. Epub 2018 Feb 20. Clin Cancer Res. 2018. PMID: 29463560
Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.
Knipper S, Tilki D, Mansholt J, Berliner C, Bernreuther C, Steuber T, Maurer T, Graefen M. Knipper S, et al. Among authors: maurer t. Eur Urol Focus. 2019 Jan;5(1):50-53. doi: 10.1016/j.euf.2018.09.014. Epub 2018 Oct 3. Eur Urol Focus. 2019. PMID: 30292421
Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer.
Horn T, Krönke M, Rauscher I, Haller B, Robu S, Wester HJ, Schottelius M, van Leeuwen FWB, van der Poel HG, Heck M, Gschwend JE, Weber W, Eiber M, Maurer T. Horn T, et al. Among authors: maurer t. Eur Urol. 2019 Oct;76(4):517-523. doi: 10.1016/j.eururo.2019.03.045. Epub 2019 Apr 12. Eur Urol. 2019. PMID: 30987843
Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy.
Leyh-Bannurah SR, Kachanov M, Beyersdorff D, Tian Z, Karakiewicz PI, Tilki D, Fisch M, Maurer T, Graefen M, Budäus L. Leyh-Bannurah SR, et al. Among authors: maurer t. J Urol. 2020 Feb;203(2):299-303. doi: 10.1097/JU.0000000000000527. Epub 2019 Sep 4. J Urol. 2020. PMID: 31483694
727 results